Table 3.

Univariable and Multivariable Proportional Hazards Analyses of the Relations between Selected Covariables and Mortality during 2 years of Follow‐up. Column A: Univariable Analyses. Column B: Multivariable Model Including Tp‐e and not HR, Column C: Model Including both Tp‐e and HR, and Column D: Model Including Heart Rate Corrected Tp‐e (cTp‐e)

	Univariable A RR [CI]	Multivariable (models B, C, and D)
		P	B RR [CI]	P	C RR [CI]	P	D RR [CI]	P
Age (+10 years)	2.1 [1.8–2.6]	<0.001	1.6 [1.3–2.0]	<0.001	1.6 [1.3–2.0]	<0.001	1.6 [1.3–2.0]	<0.001
Heart failure (yes/no)	5.0 [3.4–7.3]	<0.001	2.5 [1.6–3.8]	<0.001	2.0 [1.3–3.2]	0.003	2.2 [1.4–3.4]	<0.001
Hemoglobin (+1SD)	0.51 [0.44–0.59]	<0.001	0.67 [0.55–0.81]	<0.001	0.70 [0.57–0.85]	<0.001	0.69 [0.57–0.84]	<0.001
Creatinine (+1SD)	1.3 [1.2–1.4]	<0.001	1.1 [1.1–1.3]	0.010	1.2 [1.1–1.3]	<0.001	1.1 [1.1–1.3]	<0.001
CRP (+1SD)	1.4 [1.3–1.5]	<0.001	1.2 [1.0–1.3]	0.008	1.1 [1.0–1.3]	0.156	1.1 [1.0–1.3]	0.042
Previous PCI (yes/no)	0.30 [0.11–0.81]	0.018	0.23 [0.08–0.63]	0.004	0.25 [0.09–0.69]	0.008	0.23 [0.08–0.63]	0.004
Previous AMI (yes/no)	2.3 [1.5–3.3]	<0.001	1.7 [1.1–2.6]	0.025	1.7 [1.1–2.6]	0.021	1.7 [1.1–2.7]	0.015
Clopidogrel* (yes/no)	0.42 [0.28–0.63]	<0.001	0.43 [0.28–0.68]	<0.001	0.49 [0.32–0.78]	0.002	0.46 [0.29–0.71]	<0.001
Beta‐blocker* (yes/no)	1.4 [1.2–1.6]	<0.001	1.1 [0.76–1.7]	0.548	1.2 [0.81–1.6]	0.437	1.1 [0.80–1.6]	0.487
Tp‐e (+1SD)	1.4 [1.2–1.6]	<0.001	1.4 [1.2–1.6]	0.003	1.5 [1.3–1.7]	<0.001	‐	‐
Heart rate (+1SD)	1.7 [1.5–2.0]	<0.001	‐	‐	1.4 [1.2–1.7]	<0.001	‐	‐
cTp‐e (+1SD)	1.7 [1.5–2.0]	<0.001	‐	‐	‐	‐	1.6 [1.4–1.9]	<0.001

RR= Relative risk; CI = 95% Confidence interval,*Drugs on admission